Federal regulations require that expedited and full review level research studies be reviewed at least every 365 days (some studies may be reviewed more frequently, as determined by the IRB). Exempt study review occurs every 3 years.
As a courtesy, reminders of Continuing Review due dates are sent out automatically via email at 75 and 45 days prior to expiration. These reminders are sent only as a courtesy – ultimately, it is the investigator’s responsibility to assure that their research studies are renewed each year and do not expire. Please be mindful of the due dates and be sure to meet them so that your research study can continue without interruption.Continuing Review Requests Using IRB eSubmission System (PRAMS)
Applications for all new studies must now be submitted through the IRB eSubmission system, PRAMS. Continuing Reviews for studies that were originally submitted in PRAMS should also be submitted using PRAMS. For studies submitted through the IRB eSubmission system, it is not necessary to re-upload the supporting documents, such as consent forms or recruitment materials. The Office for Research Protections will obtain these documents directly from PRAMS.Continuing Review Requests for Studies Originally Submitted in Paper Form
The paper version of the Continuing Progress Report Form (CPR) should only be used for studies that were not submitted through the IRB eSubmission process (PRAMS). The CPR will be attached in the reminder email sent to the Principal Investigator (PI). Other study team members will receive the reminder email, but the CPR will not be attached, so as to avoid having multiple CPRs completed/returned. The CPR form (and other supporting documents, if applicable) may be mailed to The 330 Building, Suite 205 or submitted via email to ORProtections@psu.edu (all documents are to be contained within one email message as separate attachments). Please note that signatures are no longer required on the CPR form.
For more information, please see the Continuing Review topic in our Frequently Asked Questions.